Great Valley Advisor Group, Inc. Takeda Pharmaceutical CO LTD Transaction History

Great Valley Advisor Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$16.3 - $17.26 $259,985 - $275,297	-15,950 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$16.55 - $18.64 $7,546 - $8,499	456 Added 2.94%	15,950 $268,000
Q1 2021 Apr 20, 2021	BUY	$16.71 - $19.9 $45,835 - $54,585	2,743 Added 21.51%	15,494 $283,000
Q4 2020 Jan 29, 2021	BUY	$15.39 - $18.97 $196,237 - $241,886	12,751 New	12,751 $232,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.